Parkinson\'s Disease Market
Parkinson\'s Disease Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Parkinson\'s Disease Market Size and Growth
The Parkinson's Disease market is experiencing significant growth, driven by increasing prevalence, advanced therapeutics, and rising awareness. The global market size is projected to reach approximately $4.7 billion by 2025, reflecting strong demand for innovative treatment options. Ongoing research and development efforts are enhancing patient management and care solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Teva
◍ Novartis
◍ GSK
◍ AbbVie
◍ Merck
◍ Boehringer Ingelheim
◍ Amneal + Impax
◍ Lundbeck
◍ Sun Pharma
◍ Wockhardt
◍ UCB
◍ Bausch Health
◍ Acadia
The Parkinson's Disease Market is competitive, featuring key players like Teva, Novartis, GSK, AbbVie, Merck, and others. They innovate therapies, expand product portfolios, and enhance patient access, driving market growth. Sales figures vary; for instance, AbbVie reported revenue of $56 billion in 2022, reflecting strong market engagement.
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Request Sample Report
By Product
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market Growth
Request Sample Report
$ X Billion USD
